FTSE ticks up as banks offset weak oils, pharmas
2009-05-15 04:00:00.0
(Reuters) - Britain's leading share index ticked up early on Friday as Barclays (
) led banks higher on reports it was in talks to sell its asset management business BGI, but oil producers and drugmakers slipped.
By 0737 GMT, the FTSE 100
was up 8.01 points, or 0.2 percent at 4,370.59, after rising 0.7 percent on Thursday to snap a three-day losing run.
"It's going to be a push and pull between the bears and the bulls at these levels. We have a few bits of worrisome data this week after a long stream of not-so-bad bits. That has slightly rattled the bulls," said David Morrison, market strategist at GFT Global Markets.
"The question is, is this going to develop something more serious in terms of a pullback? ... It's going to be quite a tussle between the two sides."
) surged 8.1 percent after a source familiar with the matter said the lender was in talks to sell its asset management arm, Barclays Global Investors.
"Selling off an asset like that rather makes you worry what might be beneath the bonnet," Morrison said.
Within the banking sector, HSBC (
), Royal Bank of Scotland (
), Lloyds Banking Group (
) advanced 1.2 percent to 5.6 percent. Investors also looked ahead to U.S. consumer prices for April, due at 1230 GMT, and industrial production data, due at 1315 GMT, which will provide a further gauge to the state of the world's largest economy.
Japanese machinery orders fell in March, showing companies remained reluctant to spend despite signs that recession may have hit bottom. [ID:nT14922]
) gained 1.6 percent after the miner said it remained committed to a planned $19.5 billion tie-up with Chinese metals firm Chinalco, responding to talk that the deal may be revised to let more shareholders take part in a rights issue. [ID:nSYD453576]
Within the sector, BHP Billiton (
), Anglo American (
), Xstrata XTA.L, Kazakhmys (
), Lonmin (
) slipped 0.8 percent and 0.9 percent, respectively.
Drugmakers also retreated, with AstraZeneca (
) losing 0.6 percent, GlaxoSmithKline (
) rose 3.8 percent, extending Thursday's 13 percent rise after beating expectations on operating profit and resuming the payment of a final dividend.
) was set to ask the German government for up to 700 million euros ($948.9 million) in loan guarantees, financial sources close to the matter said on Thursday.
